Form 8-K 23andMe Holding Co. For: Jun 03

Go back to Form 8-K 23andMe Holding Co. For: Jun 03

Citi Reiterates Neutral Rating on 23andMe Holding (ME)

June 3, 2024 3:17 PM EDT

Citi analyst Daniel Grosslight reiterated a Neutral rating and $0.63 price target on 23andMe Holding (NASDAQ: ME).

The analyst comments "At the 2024 American Society of Clinical Oncology (ASCO) meeting, 23andMe presented early Ph2 data (as part of its ongoing Ph1/2a trial) for... More